Literature DB >> 7895457

Infections and diabetes: mechanisms and prospects for prevention.

P Pozzilli1, R D Leslie.   

Abstract

Infections remain a serious hazard for the diabetic patient. Good metabolic control is a major factor in limiting the development and spread of infections and, most importantly, the development of diabetic complications which predispose to infections. In some patients recurrent infections can pose a problem, particularly if there is evidence of secondary immunodeficiency. In these patients adjuvant therapies, including Biological Responses Modifiers (BRMS) should be considered. Several factors could predispose diabetic patients to infections. These factors include: genetic susceptibility to infection; altered cellular and humoral immune defense mechanisms; local factors including poor blood supply and nerve damage, and alterations in metabolism associated with diabetes. In the context of a diabetic patient all or some of these factors may operate. The purpose of this review is to assess the relative contribution of these potential mechanisms in leading to infection in patients with diabetes.

Entities:  

Mesh:

Year:  1994        PMID: 7895457     DOI: 10.1111/j.1464-5491.1994.tb00250.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  55 in total

1.  A Current Approach to Diabetic Foot Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

2.  Incomplete penetrance of susceptibility genes for MHC-determined immunoglobulin deficiencies in monozygotic twins discordant for type 1 diabetes.

Authors:  Chester A Alper; Zaheed Husain; Charles E Larsen; Devendra P Dubey; Rosanne Stein; Caitlin Day; Alissa Baker; Huriya Beyan; Mohammed Hawa; Thomas O Ola; R David Leslie
Journal:  J Autoimmun       Date:  2006-10-06       Impact factor: 7.094

3.  Prognostic impact of hyperglycemia at onset of methicillin-sensitive Staphylococcus aureus bacteraemia.

Authors:  E Forsblom; E Ruotsalainen; A Järvinen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-06       Impact factor: 3.267

Review 4.  Diabetic foot infections: microbiological aspects, current and future antibiotic therapy focusing on methicillin-resistant Staphylococcus aureus.

Authors:  Andreas Ambrosch; Simone Haefner; Edward Jude; Ralf Lobmann
Journal:  Int Wound J       Date:  2011-08-23       Impact factor: 3.315

5.  The association of haemoglobin A₁C levels with the clinical and CT characteristics of Klebsiella pneumoniae liver abscesses in patients with diabetes mellitus.

Authors:  Hong-Hau Wang; Shih-Hung Tsai; Chih-Yung Yu; Hsian-He Hsu; Chang-Hsien Liu; Jung-Chung Lin; Guo-Shu Huang; Wei-Tung Cheng; Ho-Jui Tung; Ching-Yang Chen; Wei-Chou Chang
Journal:  Eur Radiol       Date:  2014-02-22       Impact factor: 5.315

6.  The NFκB signaling pathway serves an important regulatory role in Klebsiella pneumoniae liver abscesses.

Authors:  Meiling Zhang; Long Pan; Dong Xu; Chuanwu Cao; Rongfeng Shi; Shilong Han; Junping Liu; Xue Li; Maoquan Li
Journal:  Exp Ther Med       Date:  2018-04-25       Impact factor: 2.447

7.  Prevalence of asymptomatic bacteriuria in type 2 diabetic subjects with and without microalbuminuria.

Authors:  Athanasia Papazafiropoulou; Ioannis Daniil; Alexios Sotiropoulos; Eleni Balampani; Anthi Kokolaki; Stavros Bousboulas; Stavroula Konstantopoulou; Eystathios Skliros; Dimitra Petropoulou; Stavros Pappas
Journal:  BMC Res Notes       Date:  2010-06-17

8.  Reduction of lipopolysaccharide-induced cyclooxygenase-2 expression in diabetic arteries.

Authors:  Yuji Takahashi; Michael Poteser; Munetaka Negoro; Ichiro Wakabayashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-20       Impact factor: 3.000

9.  Differential effect of hyperglycaemia on the immune response in an experimental model of diabetes in BALB/cByJ and C57Bl/6J mice: participation of oxidative stress.

Authors:  M R Rubinstein; A M Genaro; M R Wald
Journal:  Clin Exp Immunol       Date:  2013-03       Impact factor: 4.330

10.  Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer.

Authors:  Samantha F Ehrlich; Charles P Quesenberry; Stephen K Van Den Eeden; Jun Shan; Assiamira Ferrara
Journal:  Diabetes Care       Date:  2009-10-06       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.